Regeneron

LIBTAYO

Manufacturer:

Regeneron

Libtayo HCPCS:

J9119

HCPCS Code Descriptor:

Injection, cemiplimab-rwlc, 1 mg

Category:

J Code

Libtayo NDCs:

61755-0008-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Libtayo CPT Codes:

Potential CPT administration codes for Libtayo can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Libtayo:

LIBTAYO is an Oncology drug manufactured by Regeneron and administered via the Intravenous route of administration. The J Code: J9119 is aligned to the drug LIBTAYO.

ACCESS PRICING AND MORE BY REGISTERING

J9119 Added Date:

October 1, 2019

J9119 Effective Date:

October 1, 2019

J9119 Termination Date:

HCPCS Active

Libtayo billing and coding information can be found through Regeneron at the link below:
Libtayo patient assistance information can be found through LIBTAYO Surround at the URL: https://www.libtayo.com/support
LIBTAYO prescribing information can be found at the link below:
Information regarding LIBTAYO’s side effects can be found at MedlinePlus